Stocks
Astellas Pharma Inc.ALPMY
OTCHealthcarePharmaceuticals$14.66-0.74%
A Japan-based pharmaceutical manufacturer focused on developing and commercializing prescription medicines across oncology, urology, immunology, and rare diseases. The company generates significant revenue from global therapies such as Xtandi for prostate cancer and continues to invest heavily in cl...
Market Cap: $26.3B52W Range: $8.37 – $16.95
Congressional Interest in Astellas Pharma Inc. (ALPMY)
3 members of Congress have disclosed 13 trades in Astellas Pharma Inc. (ALPMY), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
13
Unique Politicians
3
Buys
8
Sells
5
Who in Congress Is Trading ALPMY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $15K – $50K |
| 2023-02-27 | Daniel Goldman | buy | $15K – $50K |